Back to Authors

Huang, Edmund

https://orcid.org/0000-0001-5356-9290

Mayo Clinic

Cedars-Sinai Medical Center

Citations 2

Banff 2022 Kidney Commentary: Reflections and Future Directions
Böhmig, Georg A. , Van-Groningen, Marian Clahsen, Cornell, Lynn D. , Vries, Aiko P. J. de , Huang, Edmund , Kozakowski, Nicolas , Perkowska‐Ptasińska, Agnieszka , Riella, Leonardo V. , Rosales, Ivy A. , Schinstock, Carrie, Simmonds, Naomi, Groningen, Marian C. Clahsen‐van , Riella, Leonardo V , Clahsen-van Groningen, Marian C , Cornell, Lynn , de Vries, Aiko P J , Rabant, Marion , Adam, Benjamin , Aubert, Olivier, Thaunat, Olivier , Willicombe, Michelle Kay

Transplantation | June 18, 2024 | Volume: 109 | Issue: 2 | Pages: 292-299

10.1097/tp.0000000000005112 Get It

In September 2022, in Banff, Alberta, Canada, the XVIth Banff meeting, corresponding to the 30th anniversary of the Banff classification, was held, leading to 2 recent publications. Discussions at the Banff meeting focused on proposing improvements to the Banff process as a whole. In line with this, a unique opportunity was offered to a selected group of 16 representatives from the pathology and transplant nephrology community, experts in the field of kidney transplantation, to review these 2 Banff manuscripts. The aim was to provide an insightful commentary, to gauge any prospective influence the proposed changes may have, and to identify any potential areas for future enhancement within the Banff classification. The group expressed its satisfaction with the incorporation of 2 new entities, namely “microvascular inflammation/injury donor-specific antibodies–negative and C4d negative” and “probable antibody-mediated rejection,” into category 2. These changes expand the classification, facilitating the capture of more biopsies and providing an opportunity to explore the clinical implications of these lesions further. However, we found that the Banff classification remains complex, potentially hindering its widespread utilization, even if a degree of complexity may be unavoidable given the intricate pathophysiology of kidney allograft pathology. Addressing the histomorphologic diagnosis of chronic active T cell–mediated rejection (CA TCMR), potentially reconsidering a diagnostic-agnostic approach, as for category 2, to inflammation in interstitial fibrosis and tubular atrophy and chronic active T cell–mediated rejection was also an important objective. Furthermore, we felt a need for more evidence before molecular diagnostics could be routinely integrated and emphasized the need for clinical and histologic context determination and the substantiation of its clinical impact through rigorous clinical trials. Finally, our discussions stressed the ongoing necessity for multidisciplinary decision-making regarding patient care.
Dynamic prediction of renal survival using artificial intelligence: an international study of deeply phenotyped cohorts of kidney transplant recipients
Loupy, Alexandre , Raynaud, Marc , Bailly, É. , Ladrière, Marc, Delahousse, Michel, Linhares, Kamilla, Castro, Maria Cristina Ribeiro de , Gervacio, Soler Pujol, Empana, Jean‐Philippe , Ulloa, Camilo , Böhmig, Georg A. , Huang, Edmund , Legendre, Christophe , Jouven, Xavier , Lefaucheur, Carmen , Loupy, Alexandre , Bailly, Élodie , Aubert, Olivier, Reese, Peter P. , Kamar, Nassim , Chin, Chen-Shan , Quintrec, Moglie Le , Jurić, Ivana , Bašić‐Jukić, Nikolina , Crespo, Marta , Junior, Helio Tedesco Silva , Akalin, Enver , Glotz, Denis , Stegall, Mark D. , Bentall, Andrew , Montgomery, Robert A. , Jordan, Stanley C. , Oberbauer, Rainer W. , Segev, Dorry L. , Friedewald, John J.

No container title available | October 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-85478/v1 Get It

Abstract The authors have requested that this preprint be removed from Research Square.